SillaJen Inc - Asset Resilience Ratio

Latest as of September 2025: 50.41%

SillaJen Inc (215600) has an Asset Resilience Ratio of 50.41% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

₩62.70 Billion

≈ $42.49 Million USD Cash + Short-term Investments

Total Assets

₩124.38 Billion

≈ $84.29 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2016–2024)

This chart shows how SillaJen Inc's Asset Resilience Ratio has changed over time. Check SillaJen Inc strategic asset allocation index to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down SillaJen Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see how much is SillaJen Inc worth.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	₩0.00	0%
Short-term Investments	₩62.70 Billion	50.41%
Total Liquid Assets	₩62.70 Billion	50.41%

Asset Resilience Insights

Very High Liquidity: SillaJen Inc maintains exceptional liquid asset reserves at 50.41% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

SillaJen Inc Industry Peers by Asset Resilience Ratio

Compare SillaJen Inc's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Tubize-Fin BR:TUB	Biotechnology	0.05%
Verona Pharma plc F:I9SA	Biotechnology	0.00%
Xiamen Amoytop Biotech Co Ltd SHG:688278	Biotechnology	4.69%
Syndax Pharmaceuticals Inc NASDAQ:SNDX	Biotechnology	46.79%
Neuren Pharmaceuticals Ltd AU:NEU	Biotechnology	90.43%
Vor Biopharma Inc NASDAQ:VOR	Biotechnology	63.47%
Chengdu Kanghua Biological Products SHE:300841	Biotechnology	1.19%
Jiangsu Aidea Pharmaceutical Co Ltd SHG:688488	Biotechnology	4.35%

Annual Asset Resilience Ratio for SillaJen Inc (2016–2024)

The table below shows the annual Asset Resilience Ratio data for SillaJen Inc.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	78.85%	₩117.51 Billion ≈ $79.63 Million	₩149.02 Billion ≈ $100.99 Million	+14.59pp
2023-12-31	64.26%	₩49.30 Billion ≈ $33.41 Million	₩76.71 Billion ≈ $51.99 Million	+3.88pp
2022-12-31	60.38%	₩62.46 Billion ≈ $42.33 Million	₩103.45 Billion ≈ $70.10 Million	-19.92pp
2021-12-31	80.30%	₩108.26 Billion ≈ $73.37 Million	₩134.83 Billion ≈ $91.37 Million	+36.77pp
2020-12-31	43.53%	₩20.64 Billion ≈ $13.99 Million	₩47.42 Billion ≈ $32.14 Million	+38.36pp
2018-12-31	5.18%	₩10.00 Billion ≈ $6.78 Million	₩193.19 Billion ≈ $130.92 Million	-9.29pp
2017-12-31	14.47%	₩34.00 Billion ≈ $23.04 Million	₩234.95 Billion ≈ $159.23 Million	-39.33pp
2016-12-31	53.80%	₩152.85 Billion ≈ $103.59 Million	₩284.13 Billion ≈ $192.55 Million	--

pp = percentage points

About SillaJen Inc

KQ:215600 Korea Biotechnology

Market Cap

$200.79 Million

₩296.29 Billion KRW

Market Cap Rank

#16480 Global

#579 in Korea

Share Price

₩2145.00

Change (1 day)

+3.62%

52-Week Range

₩1844.00 - ₩4975.00

All Time High

₩121250.15